Evidence map›Paper›PMID 36538582›Full record

ArticleCirculation. Cardiovascular interventions2022

Coronary Wave Intensity Analysis as an Invasive and Vessel-Specific Index of Myocardial Viability.

Matthew Ryan, Kalpa De Silva, Holly Morgan, Kevin O'Gallagher, Ozan M Demir, Haseeb Rahman, Howard Ellis, Luke Dancy, Daniel Sado, Julian Strange and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Circulation. Cardiovascular interventions, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Matthew RyanCardiovascular Division, King's College London, UK (M.R., K.D.S., H.M., K.O., O.M.D., H.R., H.E., M.M., A.M.S., D.P.).
Kalpa De SilvaCardiovascular Division, King's College London, UK (M.R., K.D.S., H.M., K.O., O.M.D., H.R., H.E., M.M., A.M.S., D.P.).ORCID 0000-0003-2436-2447
Holly MorganCardiovascular Division, King's College London, UK (M.R., K.D.S., H.M., K.O., O.M.D., H.R., H.E., M.M., A.M.S., D.P.).ORCID 0000-0002-6636-6174
Kevin O'GallagherCardiovascular Division, King's College London, UK (M.R., K.D.S., H.M., K.O., O.M.D., H.R., H.E., M.M., A.M.S., D.P.).ORCID 0000-0003-2218-4763
Ozan M DemirCardiovascular Division, King's College London, UK (M.R., K.D.S., H.M., K.O., O.M.D., H.R., H.E., M.M., A.M.S., D.P.).ORCID 0000-0001-8909-5277
Haseeb RahmanCardiovascular Division, King's College London, UK (M.R., K.D.S., H.M., K.O., O.M.D., H.R., H.E., M.M., A.M.S., D.P.).
Howard EllisCardiovascular Division, King's College London, UK (M.R., K.D.S., H.M., K.O., O.M.D., H.R., H.E., M.M., A.M.S., D.P.).ORCID 0000-0001-9004-9964
Luke DancyCardiology Department, King's College Hospital, London, UK (L.D., D.S., N.M.).
Daniel SadoCardiology Department, King's College Hospital, London, UK (L.D., D.S., N.M.).ORCID 0000-0002-7065-3942
Julian StrangeBristol Heart Institute, UK (J.S.).ORCID 0000-0003-0476-0886
Narbeh MelikianBristol Heart Institute, UK (J.S.).
Michael MarberCardiovascular Division, King's College London, UK (M.R., K.D.S., H.M., K.O., O.M.D., H.R., H.E., M.M., A.M.S., D.P.).
Ajay M ShahCardiovascular Division, King's College London, UK (M.R., K.D.S., H.M., K.O., O.M.D., H.R., H.E., M.M., A.M.S., D.P.).ORCID 0000-0002-6547-0631
Amedeo ChiribiriCardiovascular Division, King's College London, UK (M.R., K.D.S., H.M., K.O., O.M.D., H.R., H.E., M.M., A.M.S., D.P.).
Divaka PereraCardiovascular Division, King's College London, UK (M.R., K.D.S., H.M., K.O., O.M.D., H.R., H.E., M.M., A.M.S., D.P.).ORCID 0000-0001-6362-1291
Marks and Spencer (United Kingdom) · GBKing's College Hospital · GBNIHR Bristol Cardiovascular Biomedical Research Unit · GB

Funding

British Heart Foundation CH/1999001/11735British Heart Foundation FS/16/49/32320British Heart Foundation FS/18/16/33396British Heart Foundation FS/CRTF/21/24190British Heart Foundation PG/19/9/34228
6 · The paper itself

Abstract

backgroundCoronary angiography and viability testing are the cornerstones of diagnosing and managing ischemic cardiomyopathy. At present, no single test serves both needs. Coronary wave intensity analysis interrogates both contractility and microvascular physiology of the subtended myocardium and therefore has the potential to fulfil the goal of completely assessing coronary physiology and myocardial viability in a single procedure. We hypothesized that coronary wave intensity analysis measured during coronary angiography would predict viability with a similar accuracy to late-gadolinium-enhanced cardiac magnetic resonance imaging.

methodsPatients with a left ventricular ejection fraction ≤40% and extensive coronary disease were enrolled. Coronary wave intensity analysis was assessed during cardiac catheterization at rest, during adenosine-induced hyperemia, and during low-dose dobutamine stress using a dual pressure-Doppler sensing coronary guidewire. Scar burden was assessed with cardiac magnetic resonance imaging. Regional left ventricular function was assessed at baseline and 6-month follow-up after optimization of medical-therapy±revascularization, using transthoracic echocardiography. The primary outcome was myocardial viability, determined by the retrospective observation of functional recovery.

resultsForty participants underwent baseline physiology, cardiac magnetic resonance imaging, and echocardiography, and 30 had echocardiography at 6 months; 21/42 territories were viable on follow-up echocardiography. Resting backward compression wave energy was significantly greater in viable than in nonviable territories (-5240±3772 versus -1873±1605 W m

conclusionsBackward compression wave energy has accuracy similar to that of late-gadolinium-enhanced cardiac magnetic resonance imaging in the prediction of viability. Coronary wave intensity analysis has the potential to streamline the management of ischemic cardiomyopathy, in a manner analogous to the effect of fractional flow reserve on the management of stable angina.

Indexed as

CardiomyopathiesFractional Flow Reserve, MyocardialMyocardial IschemiaVentricular Dysfunction, LeftGadoliniumHumansMyocardiumRetrospective StudiesStroke VolumeTreatment OutcomeVentricular Function, LeftGadoliniumcoronary artery diseasecoronary physiologyheart failuremyocardial hibernationreduced ejection fraction

Identifiers

PMID36538582
PMCPMC9760472
OpenAlexW4312080187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.